Heterochromatin is the darkly-staining, densely-compacted chromatin of higher eukaryotes that occupies defined positions in homologous chromosomes ([@bib21], [@bib22]). Constitutive heterochromatin is generally found near centromeres and in telomeres, remains densely packaged throughout the cell cycle, and consists largely of moderately and highly repetitive sequences ([@bib42]; [@bib28]; [@bib63]).

In *Drosophila melanogaster*, about 60 Mb of DNA (roughly 1/4 of the genome) in females is found within heterochromatic regions, while in males, the 40Mb Y chromosome is almost entirely heterochromatic ([@bib1]; [@bib27]). However, while there has been extensive genetic and molecular characterization of genes in *Drosophila* euchromatin, genes in the heterochromatic regions of the genome have been much more difficult to study. Some obstacles to mapping and assembling heterochromatic sequences include an absence of significant meiotic recombination, a paucity of prominent cytological landmarks, and the high repetitive sequence content within heterochromatin.

A defining property of heterochromatin is its ability to variably "silence", in a mosaic fashion, euchromatic genes relocated immediately next to or within heterochromatin, a phenomenon called position effect variegation (PEV) (reviewed in [@bib17]). Genetic screens for second-site suppressors and enhancers of PEV have identified a large number of modifier genes, many of which encode known enzymatic products or structural components associated with establishment/maintenance of heterochromatin ([@bib16]; [@bib51]; [@bib64]; [@bib57]). Moreover, heterochromatic regions often contain signature patterns of histone modifications and bound proteins similar to those found in some silenced euchromatic gene regions, including the presence of HP1a, Su(var)3-9 and Su(var)3-7 proteins, as well as histones trimethylated at residues H3K9 and H4K20 ([@bib33]; [@bib53]).

Although heterochromatin has striking gene silencing properties, genetic analysis has demonstrated that these chromosomal regions contain active genes whose expression is essential for fly development and fertility. A large number of these genes reside in the centromeric heterochromatin of the autosomes--chromosome 2 ([@bib25]; [@bib26]; [@bib49]; [@bib10]) and chromosome 3 ([@bib43],[@bib44]; [@bib58], [@bib59]). In addition, a few essential genes are located on the X ([@bib23]; [@bib46]) and Y ([@bib5]; [@bib6]) chromosomes, as well as a number on 4, the "dot" chromosome, which has several properties consistent with a heterochromatic environment ([@bib52]).

It is interesting that heterochromatic genes can in turn be repressed when placed in euchromatic locations, strongly suggesting that these genes require a heterochromatic environment for their expression ([@bib67]; [@bib15]; [@bib30]). This hypothesis is further supported by several genetic and molecular studies which suggest that reduced dosage of the HP1a gene, which encodes a product required for heterochromatin integrity, leads to the reduced expression of some heterochromatic genes ([@bib8]; [@bib61]; [@bib41]; [@bib59]).

The first genetic screens for lethal mutations in chromosome 3 pericentric heterochromatin identified a minimum of 10 essential loci in 3L Het and 2 loci in 3R Het ([@bib43] and [@bib44]). Subsequent genetic analysis generated more 3L Het deficiencies, additional alleles of already defined 3L Het genes, as well as mutations in new essential 3L and 3R Het loci, some of which were identified molecularly (for a review, see [@bib18]).

Data providing a corresponding physical map of chromosome 3 centric heterochromatin has come from genome sequencing as well as from cytological studies., Progress from the Drosophila Heterochromatin Genome project has provided an extensive physical map from DNA sequencing data, including numerous predicted gene models in centric heterochromatin ([@bib63]; [@bib28], [@bib29]). Comprehensive ChIP-array analysis of histone modifications and chromosomal proteins has also demonstrated different chromatin packaging profiles for heterochromatic *vs.* euchromatic domains ([@bib53]).

[@bib34] used various chromosomal rearrangements and heterochromatin banding analysis to produce a cytological map of the essential 3L and 3R Het loci defined by [@bib44]. This group later refined their map using the *Suppressor of Under-Replication* ([*SuUR*](https://identifiers.org/bioentitylink/FB:FBgn0025355?doi=10.1534/g3.119.0003){#ext-link-5f8f50c3377e4c618cbc5767eeb0fc86}) mutation, which allows visualization of chromatin landmarks in the otherwise rather amorphous heterochromatin ([@bib35]). More recently, [@bib3] used FISH mapping of BAC clones containing known essential 3L and 3R Het genes on polytene chromosomes from *SuUR- Su(var)3-9* double mutants to generate a high-resolution map of heterochromatic gene models and highly repetitive satellite sequences.

A comprehensive analysis of essential genes in the centric heterochromatin of chromosome 2 has been provided by extensive genetic and molecular analyses by Hilliker ([@bib11], [@bib10]) and others ([@bib49]). In particular, [@bib10] further refined the genetic and molecular profile of the distal segment of proximal 2R Het, reducing the number of complementation groups defined by [@bib49] and identifying six additional essential loci in 2R Het via RNAi analysis . Their results complement well the extensive physical map generated by genome sequencing ([@bib28], [@bib29]) and cytological analysis ([@bib55]; [@bib14]).

Here we report on our work to obtain a comprehensive genetic map of chromosome 3L Het. We focused on the identification of essential genetic loci and their alignment with predicted gene models on the physical map, with the overall aim of obtaining a functional annotation of essential genes in this region. This and our previous work has also facilitated the characterization of a number of interesting essential genes in centric heterochromatin *e.g.*, [@bib59], [@bib38], [@bib19], [@bib20]), [@bib62], as well as genes described in this report.

Briefly, we focused initially on compiling a collection of new genetic lesions, followed by genetic deficiency mapping and a large scale *inter se* complementation analysis to define genetic loci. Next, we used a PCR-based mapping approach to localize putative heterochromatic sequences from the available genome assembly to defined heterochromatic intervals, thereby allowing us to identify candidate gene(s) for each essential complementation group. We then identified essential loci present by correlating gene sequences to lethal complementation groups, coupled with RNA interference studies (see also [@bib20] for examples). Most of the original lethal 3L Het complementation groups identified by Marchant and Holm have now been defined at the molecular level and we have also identified additional essential loci.

Our analysis has revealed a surprisingly high percentage of essential genes in 3L Het. The work also provides an expanded repertoire of genetic reagents, such as deletions (especially those with molecularly defined breakpoints), as well as novel lethal mutations (EMS-, *P*-element- and radiation-induced); these will be valuable tools for developing a comprehensive profile of gene functions in chromosome 3 heterochromatin.

Materials and Methods {#section-74c07a8060161a8b92a0fa12be4798af}
=====================

Fly strains and crosses {#section-28c1ed240ded7ece0bcae8ffa5483a93}
-----------------------

Flies were raised on standard yeast-molasses-cornmeal medium and fly strains were maintained at 18°. Crosses were performed at 25° unless otherwise stated and all crosses were scored to completion. If no transheterozygous progeny emerged, or if the number of transheterozygous progeny was less than 5% of those expected from balancer classes (minimally, 100 balancer heterozygotes were examined per cross), the combination was considered lethal. In cases where the transheterozygotes were greater than 5% but substantially less than 50% of those expected, the combination was considered semi-lethal.

Unless otherwise stated, genetic strains used have been reported elsewhere. The G series of EMS-induced lines, as well as *Df(3L)FX3*, *DF(3L)FX53*, *Df(3L)FX33* and *Df(3L)MX18* were created in the Deitcher laboratory ([@bib66]; [@bib59]; D. Deitcher personal communication). The Z series of EMS mutations was obtained from the Zuker collection ([@bib36]). EMS lines *2-30* and *1-166-38*, as well as the γ-radiation-induced deficiencies *Df(3LR)6B-29*, *Df(3L)1-166*, *Df(3L)9-56*, *Df(3L)2-30* and *Df(3L)8-80* were generated by [@bib43]. The *P*-element alleles *CH(3)4*, *CH(3)119*, *CH(3)4d*, *CH(3)53* and *CH(3)7* were generated by [@bib69] and were generously provided by P. Zhang. *Df(3L)O-1*, *Df(3L)K2* and *Df(3L)γ-28* were generated as described in [@bib58].

X-ray mutagenesis and genetic screens {#section-41292e2a3ed2dfec275a3f06559e8a8c}
-------------------------------------

Three- to five-day old *KG03264/KG03264* males (carrying a P{SUPor-P} insert at cytological position 80C1 near the [*nrm*](https://identifiers.org/bioentitylink/FB:FBgn0262509?doi=10.1534/g3.119.0003){#ext-link-c7d5a09059bccbe0ab7d80e816d2a1a1} locus) were treated with 4,000 rads of X-ray radiation, allowed to recover for 24 hr, and crossed [en](https://identifiers.org/bioentitylink/FB:FBgn0000577?doi=10.1534/g3.119.0003){#ext-link-795f01886f760f2117555a420743fad4}*masse* to TM3 Sb [Ser](https://identifiers.org/bioentitylink/FB:FBgn0004197?doi=10.1534/g3.119.0003){#ext-link-0e4df6e5a75cedff830bf1e9f6a12cc8}/TM6 Hu [Tb](https://identifiers.org/bioentitylink/FB:FBgn0243586?doi=10.1534/g3.119.0003){#ext-link-2c283c6e64181241e658b383db9e9c29} virgin females. Approximately one thousand single F1 *KG03264{w^+^}*\*/TM3 Sb [Ser](https://identifiers.org/bioentitylink/FB:FBgn0004197?doi=10.1534/g3.119.0003){#ext-link-a89f520c8833e06077ad9c048db1ee0b} or *KG03264{w^+^}*\*/TM6 Hu [Tb](https://identifiers.org/bioentitylink/FB:FBgn0243586?doi=10.1534/g3.119.0003){#ext-link-2de66dc3ace409575af66f61e5e4ade1} males (where \* indicates a mutagenized third chromosome) were then crossed to virgin females carrying a 3L Het deficiency (*Df(3L)FX3*/TM3 [Ser](https://identifiers.org/bioentitylink/FB:FBgn0004197?doi=10.1534/g3.119.0003){#ext-link-19bcb19f1405da53ef9deec86fc4e9c4} or *Df(3L)MX18* /*TM3 Ser)*, and the resulting progeny were examined for lethality or visible phenotypes. Stocks of putative lethal mutations were established from *KG03264{w^+^}\**/TM3 [Ser](https://identifiers.org/bioentitylink/FB:FBgn0004197?doi=10.1534/g3.119.0003){#ext-link-5a19574d2c61244ab3e5d3c998fca849} siblings. To further map the newly-isolated lesions, all mutations were separately crossed to flies bearing a subset of smaller 3L Het deficiencies (*Df(3L)1-166*, *Df(3L)γ28*, *Df(3L)K2*, *Df(3L)9-56*, *Df(3L)FX33*), and to at least two existing alleles of each lethal complementation group (except where only a single allele existed).

We then conducted a second X-ray screen, designed to isolate lethal lesions in both 3L Het and 3R Het. In this study, 3- to 5-day old *e^1^/e^1^* males were treated with 4,000 rads of X-ray radiation and crossed *en masse* to TM3 e^1^ Sb [Ser](https://identifiers.org/bioentitylink/FB:FBgn0004197?doi=10.1534/g3.119.0003){#ext-link-b9a2ec3844d115e9f709135c786d3666}/TM6 e^1^ Hu [Tb](https://identifiers.org/bioentitylink/FB:FBgn0243586?doi=10.1534/g3.119.0003){#ext-link-0ac14b187e72db4d51a0eaebcd9d805b} virgin females. Single F1 *e^1^*\*/TM3 e^1^ Sb [Ser](https://identifiers.org/bioentitylink/FB:FBgn0004197?doi=10.1534/g3.119.0003){#ext-link-92690952db8971d4acaa2bfb82787e5f} males (where \* indicates a mutagenized third chromosome) were then crossed to *Df(3LR)6B-29*/TM3 e^1^ [Ser](https://identifiers.org/bioentitylink/FB:FBgn0004197?doi=10.1534/g3.119.0003){#ext-link-b389940fd5de88433a3d6b9bb7bab84f} females, and stocks of putative lethal mutations established from *e^1^\**/TM3 e^1^ [Ser](https://identifiers.org/bioentitylink/FB:FBgn0004197?doi=10.1534/g3.119.0003){#ext-link-d63ee03c5c30e7896358a69ca2b78d2a} siblings. To further map the newly isolated lesions, we crossed all mutations to the subset of smaller heterochromatic deficiencies, as described above, with the addition of *Df(3R)10-65* and *Df(3R)XM3*, as well as to alleles of each lethal complementation group.

Screen of the EMS Zuker collection {#section-add27c5320df4bd0fac74d2373e143aa}
----------------------------------

We obtained 3,400 strains (balanced with TM6 e^1^ [Tb](https://identifiers.org/bioentitylink/FB:FBgn0243586?doi=10.1534/g3.119.0003){#ext-link-bb7fd6fe2b5f7b224fea48e740b6a5c0}) from the Zuker collection that contained putative third chromosome mutations generated with EMS, because it had been reported that approximately one third of the Zuker strains contained third chromosome lethal mutations ([@bib36]). We tested each balanced line for lethality with different 3L or 3R Het Df/TM6 [Tb](https://identifiers.org/bioentitylink/FB:FBgn0243586?doi=10.1534/g3.119.0003){#ext-link-c99318b290f2c79481caa3d9a6585109} strains: *Df(3LR)6B-29*, *Df(3L)FX53*, *Df(3L)Delta1AK and Df(3R)XM3*. Confirmed lethal mutations were then further mapped by using *Df(3L)γ28*, *Df(3L)K2*, *Df(3L)9-56*, *Df(3L)FX33*, *Df(3R)XM3* and *Df(3R)10-65*, each balanced over TM6B [Tb](https://identifiers.org/bioentitylink/FB:FBgn0243586?doi=10.1534/g3.119.0003){#ext-link-c0e1d6af8c52d61034f2b05176861d2f}. In addition, we tested the lethals for allelism with representative alleles of appropriate lethal complementation groups.

Single embryo PCR for detection of homozygous mutant embryos, deficiency mapping, and sequencing of mutant alleles {#section-53ac63b4bf5f5dfb437808b5ce7abb1a}
------------------------------------------------------------------------------------------------------------------

We isolated embryos homozygous for chromosomal deficiencies and other induced mutations using the methodology described in [@bib19]; [@bib20]). In brief, using DNA from homozygous deficiency strains, along with PCR mapping primers for candidate gene sequences (see Table S1), we tested for the presence or absence of PCR products in homozygous mutant embryos from each strain. The absence of a PCR product indicated that a specific gene sequence mapped to the region covered by the deficiency.

For sequence analysis, DNA was isolated from homozygous mutant embryos, all exon regions were PCR amplified, and purified PCR products were then sequenced to look for corresponding DNA lesions that might result in mutant phenotypes (see [@bib19], [@bib20]). DNA sequencing was performed by UBC NAPS or Genewiz or Macrogen sequencing services. Mutations were identified by comparing sequences to the reference sequences available on Flybase using the BLAST algorithm ([@bib2]) and multiple protein alignments were carried out using CLUSTALW ([@bib37]).

RNA interference experiments {#section-5bd5e37c78c37a27ca62a63cd3363159}
----------------------------

Transgenic UAS-RNAi lines, expressing inverted repeats (IRs) under the control of *Gal4*, were obtained from the Vienna Drosophila RNAi Center (VDRC: <http://stockcenter.vdrc.at/control/main>), Drosophila Transgenic RNAi Project (TriP: <http://www.flyrnai.org/TRiP-HOME.html>) and the Fly Stocks of the National Institute of Genetics (NIG-fly; <http://www.shigen.nig.ac.jp/fly/nigfly/index.jsp>). We crossed UAS-IR-bearing males to virgin females, initially held at 29° for at least two days, bearing *UAS-Dcr-2/UAS-Dcr-2*; tub-Gal4/TM3 [Sb](https://identifiers.org/bioentitylink/FB:FBgn0003319?doi=10.1534/g3.119.0003){#ext-link-d9923fa0d3ec5511aefa0d84f79a3171}. Actin and tubulin driver stocks were used to induce ubiquitous expression of the IR transgenes and a copy of *UAS-Dcr2* (a component of the RNAi pathway) was included to sensitize the RNAi interference pathway and enhance knockdown. We maintained crosses at 29° and then examined them for lethality, sterility and visible phenotypes in flies expressing the IR sequence. Crosses producing UAS-IR driven progeny, but at proportions substantially less than 50% of those expected from the balancer classes, were deemed semi-lethal (due to the incomplete penetrance/ expression of RNA, some "escapers" may survive).

Data Availability {#section-5ec8c2fc60fc48c33c0b35f48965ec78}
-----------------

A comprehensive and representative set of stocks have been sent to Dr Kevin Cook at the Bloomington Drosophila stock center. Supplemental files available at FigShare. Table S1 lists primers used in mapping. Table S2 lists EMS mutations identified. The authors affirm that all data necessary for confirming the conclusions of the article are present within the article, figures, and tables. Supplemental material available at Figshare: <https://doi.org/10.25387/g3.7828301>.

Results {#section-3b2a989a63d5a7d123012abe65bcf4c8}
=======

As a first step in our analysis, we generated and mapped a large number of additional lethal lesions (putative Dfs and/or point mutations) within 3L and 3R Het. To do this, we conducted two X-ray mutagenesis screens, and in parallel screened 3,400 EMS-mutagenized 3^rd^ chromosomes from the Zuker collection ([@bib36]), as outlined in Materials and Methods.

From these large-scale genetic screens, we isolated 91 novel lesions (46 from the X-ray screens, 45 from the Zuker lines), and of these, 60 mapped to 3L Het and 14 to 3R Het ([Table 1](#t1){ref-type="table"}). The remaining 17 mutations may be located outside of 3^rd^ chromosome heterochromatin, possibly due to the presence of second site lethal mutations outside of 3L Het, see below.

###### Summary of results from EMS and X-ray screens

  Mutagen     3L lesions   3R Lesions   Total number of lesions   Number of chromosomes   Df used for screening         Frequency of lesions
  ----------- ------------ ------------ ------------------------- ----------------------- ----------------------------- ----------------------
  X-ray \#1   14           0            14                        ∼1000                   FX3, MX18                     1.40%
  X-ray \#2   25           7            32                        3829                    6B-29                         0.84%
  EMS         21           7            45\*                      3400                    6B-29, Delta1-AK, FX53, MX3   1.32%

Screens for lethal lesions in 3L and 3R Het induced by X-rays {#section-85b948ee49eb50a0b6dc39bab8b51ab1}
-------------------------------------------------------------

Our first X-ray screen with the large *Df(3L)FX3* and *Df(3L)MX18* deficiencies identified 14 lesions in 3L Het (X-ray \#1 in [Table 1](#t1){ref-type="table"}). To position the new lesions more definitively, we tested them for complementation with deficiencies removing specific intervals of 3L Het and with alleles of previously identified essential loci. Of the aforementioned 14 lesions, 11 failed to complement *Df(3L)FX3* (see [Figure 1](#fig1){ref-type="fig"}). The remaining three mutations (*Df(3L)Lola*, *Df(3L)BAC and Df(3L)ZZZ*) were *Minute*-like in phenotype in combination with *Df(3L)FX3* or *Df(3L)MX18*, but it was not possible to map these lesions further. The combined frequency of lethal and *Minute*-like lesions generated in this screen was 1.4%. The putative X-ray-induced lesions varied in size; some were large and spanned several lethal complementation groups, corresponding to many megabases of DNA (*e.g.*, *Df(3L)TTT*) ([Figure 1](#fig1){ref-type="fig"}), whereas others were either small deletions/other rearrangements or possibly point mutations affecting single genes (*e.g.*, *Df(3L)GGG*) ([Figure 1](#fig1){ref-type="fig"}).

![Genetic map of EMS mutants and deficiencies isolated from our initial screens of Zuker lines and first X-ray screen. Blue lines - newly discovered deficiencies; red lines - deficiencies used to screen for new lesions; green circles - newly-mapped EMS lesions from the Zuker collection. Dashed lines on deficiencies indicate semi-lethality with alleles of intersecting complementation groups. *Df(3L)WWW* may be a discontinuous lesion affecting at least two genes (*lethal 6* and *lethal 7A*).](1581f1){#fig1}

In a subsequent larger-scale X-ray screen (X-ray \#2 in [Table 1](#t1){ref-type="table"}), we screened the mutagenized chromosomes for failure to complement *Df(3LR)6B-29*, a large deficiency removing heterochromatic segments from both 3L and 3R (Marchant and Holm *op. cit*.). In total, we isolated 32 lesions in this second screen: 25 on 3L and 7 on 3R. Of the 25 putative 3L Het deficiencies isolated in our second X-ray screen, 21 were used for further analysis (see [Figure 2](#fig2){ref-type="fig"}). We then performed *inter se* complementation tests of each of these lesions in combination with various other 3L Het deficiencies and in combination with representative alleles of existing complementation groups, in order to position the new lesions along the chromosome arm (see [Figure 2](#fig2){ref-type="fig"} for a summary).

![Map of deficiencies generated in a more intensive, second X-ray screen. Positioning was also obtained by crossing new deficiency strains to alleles affecting essential loci and other deficiencies. Note that of the 25 deficiencies isolated, 2 were not used further (not shown) and 1 was viable with alleles of all representative complementation groups we tested in 3L Het.](1581f2){#fig2}

Screening for lesions induced by EMS in 3L and 3R Het {#section-d52185d56e6fbf2707daa62f628055c4}
-----------------------------------------------------

As described in Materials and Methods, an initial screen of recessive lethal lines from the Zuker EMS collection ([@bib36]) involved testing each strain for lethality in combination with *Df(3LR)6B-29*, a deficiency that removes much of chromosome 3 heterochromatin ([@bib43]). All putative 3L and 3R Het lethal mutations identified in this analysis were tested with four other deficiencies that remove segments of 3^rd^ chromosome centric heterochromatin (*Df(3L)Delta1-AK*, *Df(3L)FX53*, *Df(3L)FX3*, and *Df(3R)XM3)*. Of the 45 3L Het EMS lesions identified ([Table 1](#t1){ref-type="table"}), 44 were lethal or semi-lethal in combination with one of the four deficiencies. The single lesion (*Z-4493*) that was viable *in trans* with all four deficiencies was characterized by a curly wings phenotype when tested in combination with *Df(3R)XM3*. Three other lesions also caused visible phenotypes (black deposits at leg joints, abnormal positioning of legs and curled wings) and were also semi-lethal when hemizygous over particular deficiencies.

Of the 45 EMS mutations identified (designated with an asterisk in [Table 1](#t1){ref-type="table"}), 21 could be assigned unequivocally to 3L Het, based on complementation tests with *Df(3L)FX53*, *Df(3L)Delta 1-AK* or *lethal 1* alleles (see Table S2). Seventeen of these 21 lesions were allelic with previously identified complementation groups, 2 failed to complement *Df(3L)Delta 1-AK* (distal to *SNAP-25*), 1 (*Z-855*) was semi-lethal in combination with *Df(3L)FX53*, and 1 failed to complement *Df(3L)K2* and *Df(3L)1-166*. An additional seven lesions were found to be allelic with complementation groups in 3R Het.

None of the remaining 17 lesions could be assigned to known lethal complementation groups in either 3L or 3R Het. It is likely that at least some of the additional mutations are allelic to second-site mutations carried by the deletion chromosomes used for complementation analysis, as accumulation of lethal mutations on permanently heterozygous chromosomes has been well-documented ([@bib48]).

Our analyses revealed a few inconsistencies with respect to the previously published 3L Het map ([@bib18]), as well as one erroneous allele assignment. Our revised genetic map now places *Snap-25* and *lethal 6* distal to *lethal 8*, which in turn was placed distal to *lethal 7A* and *7B* ([Figure 2](#fig2){ref-type="fig"}). This gene order is now consistent with the physical map provided by genome sequencing ([@bib29]), and this order was also confirmed by our mapping and sequencing of lethal complementation groups corresponding to these published gene models. Finally, allele *G1e* was previously incorrectly assigned to *lethal 7B* rather than *lethal 4B*.

Refining the 3L Het physical map {#section-d4a783c739bbcb1c8b80c96822b31773}
--------------------------------

In order to align the genetic and physical maps of 3L Het, we mapped candidate essential genes to specific genetic intervals as defined by our deficiency maps. Using DNA from homozygous deficiency strains and primers for a set of candidate genes, we tested for the presence or absence of PCR products in flies homozygous for a given deficiency strain. The absence of a PCR product indicated that a specific gene sequence was removed by the deficiency. We then refined our analysis by using reference sequences in the physical map as anchor points for our genetic map, limiting the number of candidate genes required for testing with each deficiency.

In order to better align the genetic complementation map to the published heterochromatic sequence in Release 6 ([@bib29]), we also mapped endpoints of several large and/or distal deficiencies by PCR relative to 3L Het candidate gene sequences. Since to date, few mutations have been mapped to the distal segment of 3L Het (*e.g.*, between *Snap-25* and *Mes 2*), we were especially interested in determining the distal-most extent of *Df(3L)TTT*. PCR analysis of homozygous *Df(3L)TTT* embryos showed that this deficiency removes the [*CG40470*](https://identifiers.org/bioentitylink/FB:FBgn0058470?doi=10.1534/g3.119.0003){#ext-link-6bc14e9b60150b3d9e08e45ebee79026}, [*CG17698*](https://identifiers.org/bioentitylink/FB:FBgn0040056?doi=10.1534/g3.119.0003){#ext-link-2c3fa950814c5a896bd1d757c8f62840} and *ago3* loci, but not the *α-catenin* or the *n-AchRA4* genes ([Figure 3](#fig3){ref-type="fig"}). From our complementation analysis and single embryo PCR mapping data, we conclude that *Df(3L)TTT* deletes a region predicted to contain at least 3 Mb of DNA. A summary of our refined map is presented in [Figure 4](#fig4){ref-type="fig"}.

![Determining the distal extent of *Df(3L)TTT* by gene-specific PCR. [*CG40470*](https://identifiers.org/bioentitylink/FB:FBgn0058470?doi=10.1534/g3.119.0003){#ext-link-d4afb5b1405363f5870a3181f3d0cbda} is a gene located between *SNAP-25* and *l6*. Prior genetic analysis confirmed that *Df(3L)TTT* failed to complement alleles of essential genes located in the 3L Het segment extending from *lethal 3* to *SNAP-25*. *Df(3L)gamma-28*, which does not delete the regions tested, was used as a positive control.](1581f3){#fig3}

![Refined map of 3L Het incorporating genetic and molecular data from this study. Blue marks deficiencies in which extent was determined genetically and molecularly. Red marks deficiencies in which limits were determined genetically. "?" denotes boundary limits that have not been molecularly defined.](1581f4){#fig4}

Correlation of gene models with lethal complementation groups {#section-76b6c40672678343ddc510ab2764b43c}
-------------------------------------------------------------

Our molecular analysis of deficiency strains combined with deletion mapping of essential genes allowed us to narrow the number of candidate genes that could potentially correspond to each genetically identified locus on our map. In an attempt to determine the molecular identity of each vital locus, we amplified and sequenced the entire coding region of each candidate gene from DNA homozygous for mutant alleles representative of a given complementation group. The presence of a significant sequence change (*e.g.*, predicted deleterious effects on gene product) relative to the control background sequence, led us to conclude that a given complementation group corresponded to the candidate gene in which the change was found. In certain cases, we were also able to rescue flies containing appropriate mutations transheterozygous to deficiencies removing the candidate gene by expressing a *Gal4* driven cDNA transgene of the corresponding gene of interest. Essential genes identified using this method are listed in [Table 2](#t2){ref-type="table"}; with putative or confirmed functions of these genes included in [Table 6](#t6){ref-type="table"}. Taken together with the RNAi results described below, the data from these analyses have allowed us to assign a molecular identity for each lethal complementation group present on our genetic map (shown in [Figure 4](#fig4){ref-type="fig"}).

###### Known lethal complementation groups in 3L Het, and their molecular assignment based on the DNA lesions identified in mutants. (\*These designations based on those used in [@bib43],[@bib44]). More comprehensive data for lethal 6 (*nvd*) will be reported in Syrzycka *et al*. manuscript in preparation

  \*Lethal complementation group:   Mutant Allele(s):   Mutagen:         Gene Affected:                                                    Resulting change:         Source
  --------------------------------- ------------------- ---------------- ----------------------------------------------------------------- ------------------------- ---------------------
  lethal 1                          In(3L)C90           γ-ray            CG17514                                                           Genes missing             [@bib44]
                                                        eIF-4B/CG10837                                                                                               
  Df(3L)2-30                        γ-ray               eIF-4B/CG10837   Gene missing                                                      [@bib44]                  
  Z-4577                            EMS                 CG17514          W1092 \> STOP                                                     Zuker collection          
                                                                                                                                           ([@bib36])                
  Z-1261                            EMS                 unidentified     unidentified                                                      Zuker collection          
                                                                                                                                           ([@bib36])                
  lethal 2                          See [@bib59]        Various          RpL15/CG17420                                                     See [@bib59]              [@bib59]
  lethal 3                          See [@bib19]        Various          *rad21/vtd* (cohesin) CG17436                                     See [@bib19]              [@bib19]
  lethal 4A                         CH(3)53             P-element        CG40178                                                           P insertion in intron     [@bib69]
  CH(3)4d                           P-element           CG40178          P insertion in intron                                             [@bib69]                  
  Z-110                             EMS                 CG40178          L326 \> STOP                                                      Zuker Collection          
                                                                                                                                           ([@bib36])                
  G8                                EMS                 CG40178          W377 \> STOP                                                      Deitcher laboratory       
                                                                                                                                           ([@bib66])                
  G47                               EMS                 CG40178          K171 \> STOP                                                      Deitcher laboratory       
                                                                                                                                           ([@bib66])                
  G6                                EMS                 CG40178          K180 \> STOP                                                      Deitcher laboratory       
                                                                                                                                           ([@bib66])                
  lethal 4B                         G10                 EMS              CG17374                                                           A1463 \> T                Deitcher laboratory
                                                                                                                                           ([@bib66])                
  G11                               EMS                 CG17374          R1542 \> STOP                                                     Deitcher laboratory       
                                                                                                                                           ([@bib66])                
  G30                               EMS                 CG17374          G1780 \> E                                                        Deitcher laboratory       
                                                                                                                                           ([@bib66])                
  Z-5413                            EMS                 CG17374f         G1779 \> R                                                        Zuker Collection          
                                                                                                                                           ([@bib36])                
  Z-760                             EMS                 CG17374          I240 \> S                                                         Zuker Collection          
                                                                                                                                           ([@bib36])                
  Z-1973                            EMS                 CG17374          A1060 \> V                                                        Zuker Collection          
                                                                                                                                           ([@bib36])                
  3\#69                             EMS                 CG17374          R67 \> S                                                          D. Sinclair               
                                                                                                                                           (unpublished)             
  lethal 5                          See [@bib20]        Various          *Set1*/CG40351                                                    See [@bib20]              [@bib20]
  lethal 7A                         fsa^2^l(3)          EMS              CG40002                                                           Gene missing              Kennison and Tamkun
                                                                                                                                           (unpublished)+            
  lethal 7B                         G43                 EMS              Scro/CG17594                                                      L250 \> STOP              Deitcher laboratory
                                                                                                                                           ([@bib66])                
  Z-211                             EMS                 Scro/CG17594     P insertion of "A" nucleotide leading to frameshift at a.a. 293   Zuker Collection          
                                                                         ([@bib36])                                                                                  
  Z-247                             EMS                 Scro/CG17594     P insertion of "A" nucleotide leading to frameshift at a.a. 293   Zuker Collection          
                                                                         ([@bib36])                                                                                  
  lethal 8                          K125                P-element        mRpS5/CG40049                                                     P insertion in intron 2   Current study
  Z-1555                            EMS                 mRpS5/CG40049    ATG to ATA                                                        Zuker Collection          
                                                                                                                                           ([@bib36])                
  Z-512                             EMS                 mRpS5/CG40049    G201 \> E                                                         Zuker Collection          
                                                                                                                                           ([@bib36])                
  G18                               EMS                 mRpS5/CG40049    No lesion detected                                                Deitcher Laboratory       
                                                                                                                                           ([@bib66])                

While most of the gene assignments summarized in [Tables 2](#t2){ref-type="table"} and [6](#t6){ref-type="table"} were straightforward, the molecular and genetic characterizations of *lethal 1* and *lethal 7A* were slightly more complicated; these are therefore described in more detail below.

Molecular characterization of lethal 1 {#section-dbcfbe48b62df080931adc7fa5d69b06}
--------------------------------------

*lethal 1* is the proximal-most genetically identified essential locus in 3L Het (see [Figures 4](#fig4){ref-type="fig"} and [5](#fig5){ref-type="fig"}). The locus was originally identified in mutagenesis screens conducted by [@bib44] and it has been defined as a putative *trithorax group (trxG*) gene ([@bib58]). Numerous *lethal 1* alleles were isolated by Marchant and Holm (1988) and [@bib58], suggesting that it may encode a large mutagenesis target; however, only two of the original mutations remain: *Df(3L)2-30* and *In(3L)C90*. *Df(3L)2-30* is associated with a duplication of proximal heterochromatic material between h48 and h50 ([@bib34]), but it also likely carries a small deletion not detected by cytological analysis. *In(3L)C90* is an inversion with a heterochromatic breakpoint near or within *lethal 1*, and a euchromatic breakpoint in 62D2-7 ([@bib40]). We have also identified two additional putative *lethal 1* alleles, *Z-1261* and *Z-4577*, both of which fail to complement deficiencies that lack the gene. In combination, these two alleles produce a small number of sterile transheterozygotes with a *Minute*-like phenotype, and extra wing vein material ([Table 3](#t3){ref-type="table"}). The conventional *Minute* phenotype is haplo-abnormal and thus dominant, and is characterized by developmental delay, shorter and thinner bristles, roughened/reduced eyes, misrotated genitalia, and, often, semi-sterility; this phenotype is most often caused by defects in global protein synthesis (see [@bib45]).

![Mapping of elF-4B and [CG17514](https://identifiers.org/bioentitylink/FB:FBgn0039959?doi=10.1534/g3.119.0003){#ext-link-66eeefd49812437056b7c7a588d5fe96}. A) Molecular positioning *eIF-4B* and [*CG17514*](https://identifiers.org/bioentitylink/FB:FBgn0039959?doi=10.1534/g3.119.0003){#ext-link-3b6f56c9f154061f22c411df83b3dbcb} in the lethal 1 region. B) [*CG17514*](https://identifiers.org/bioentitylink/FB:FBgn0039959?doi=10.1534/g3.119.0003){#ext-link-2e254e33c893f7f56b576da8a7073585} and *eIF-4B* are deleted by *Df(3L)2-30*, and *eIF-4B*, but not [*CG17514*](https://identifiers.org/bioentitylink/FB:FBgn0039959?doi=10.1534/g3.119.0003){#ext-link-a79d47cff7d54dccc9b18eeafe451698}, is deleted in the *In(3L)C90* strain.](1581f5){#fig5}

###### *lethal 1 inter se* complementation matrix. ^M^All transheterozygous progeny were *Minute*-like. % expected = number of observed progeny / number of expected progeny based on balancer classes (*i.e.*, O/E)\*100%. \*In addition to deleting *lethal 1, Df(3L)9-56, Df(3L)1-166, Df(3L)e\*\#54* and *Df(3LR)6B-29* remove the *lethal 2* (*rpL15*) locus and are *Minute* because of this (data not shown)

                          *Z -1261*                  *% expected*   *Z-4577 (W1092STOP)*            *% expected*
  ----------------------- -------------------------- -------------- ------------------------------- --------------
  ***Df(3LR)6B-29***\*    20^M^ / 162 total          49%            2 ^M^ / 195 total               4%
  ***Df(3L)1-166***\*     11^M^ / 148 total          30%            8 ^M^ / 182 total               18%
  ***Df(3L)9-56***\*      1^M^ / 111 total           4%             0 / 186 total, *i.e.*, LETHAL   0%
  ***Df(3L)e\*\#54***\*   5^M^ / 214 total           9%             5 ^M^ / 249 total               8%
  ***In(3L)C90***         1^M^ / 129 total           3%             19 ^M^ / 280 total              27%
  ***Df(3L)2-30***        24^M^ sterile / 203        47%            11^M^ sterile / 147 total       30%
  ***Z- 4577***           6^M^ sterile / 229 total   11%            Homozygous lethal               N*/*A
  ***Z- -1261***          Homozygous lethal          N*/*A          6^M^ sterile / 229 total        11%

In single embryo PCR mapping ([Figure 5A](#fig5){ref-type="fig"}) two potential candidate genes were absent from *Df(3L)2-30*: *eIF-4B (eukaryotic Initiation Factor 4B* or *CG10837)*, a member of the eukaryotic initiation factor complex required for translational activation, and [*CG17514*](https://identifiers.org/bioentitylink/FB:FBgn0039959?doi=10.1534/g3.119.0003){#ext-link-9d5906a45eff2613a2a9f80651632bf6}, a large translation activator. However, *In(3L)C90* deletes *eIF-4B* but not [*CG17514*](https://identifiers.org/bioentitylink/FB:FBgn0039959?doi=10.1534/g3.119.0003){#ext-link-667681fb875d045475f2e4cfad738a71} ([Figure 5C](#fig5){ref-type="fig"}). This was somewhat surprising to us, because *lethal 1* is quite mutable, and because [*CG17514*](https://identifiers.org/bioentitylink/FB:FBgn0039959?doi=10.1534/g3.119.0003){#ext-link-9c070b311d437489e8ba3cc5415ea6b3} encodes a much longer protein (2,630 aa) than *eIF-4B* (459 aa); it therefore seemed more likely to us that *lethal 1* would correspond to [*CG17514*](https://identifiers.org/bioentitylink/FB:FBgn0039959?doi=10.1534/g3.119.0003){#ext-link-55a914319282b5c2a4aa34f977bac0db}. One possible explanation for the presence of [*CG17514*](https://identifiers.org/bioentitylink/FB:FBgn0039959?doi=10.1534/g3.119.0003){#ext-link-f6a31864cdef5d7cc78db22abf3d345a} exon sequences in *In(3L)C90* could be that only regulatory regions are mutated, and thus [*CG17514*](https://identifiers.org/bioentitylink/FB:FBgn0039959?doi=10.1534/g3.119.0003){#ext-link-7f096c43ac3c1772b5ab60c65547a27f} expression could still be affected.

Indeed, subsequent sequence analysis of mutant alleles provided evidence to identify [*CG17514*](https://identifiers.org/bioentitylink/FB:FBgn0039959?doi=10.1534/g3.119.0003){#ext-link-acdf2f2cf35dac8f0bea8778f05b383c} as corresponding to *lethal 1*: the EMS-induced *lethal 1* allele *Z-4577* contains a mutation predicted to change of residue W1092 in the [*CG17514*](https://identifiers.org/bioentitylink/FB:FBgn0039959?doi=10.1534/g3.119.0003){#ext-link-cf290a9e328580551ecac99ea0fc374f} product to a stop codon, strongly suggesting that [*CG17514*](https://identifiers.org/bioentitylink/FB:FBgn0039959?doi=10.1534/g3.119.0003){#ext-link-c307d343335856f75e2429621b3e6c8d} corresponds to the *lethal 1* locus.

In order to obtain additional support for our contention that *lethal 1* corresponds to [*CG17514*](https://identifiers.org/bioentitylink/FB:FBgn0039959?doi=10.1534/g3.119.0003){#ext-link-2f7be312e5c96862d65f4c695334192c}, we carried out RNAi knockdown of *CG17514*; in this analysis, we crossed flies containing UAS responsive [*CG17514*](https://identifiers.org/bioentitylink/FB:FBgn0039959?doi=10.1534/g3.119.0003){#ext-link-7c86684d0c407e3279c059eaabc93f8d} IRs to flies carrying the *tub-GAL4* transgene at 29° in order to activate targeting RNAi. Expression of 2 out of the 3 [*CG17514*](https://identifiers.org/bioentitylink/FB:FBgn0039959?doi=10.1534/g3.119.0003){#ext-link-5d0f4d38e64f38aed705c5a83b26c210} RNAi lines, VDRC 47269 and BL34355, resulted in reduced viability and complete lethality respectively. Escaper progeny expressing RNAi from the BDRC 47269 line display a *Minute*-like phenotype (thin bristles) and are sterile ([Table 4](#t4){ref-type="table"}). Taken together with the aforementioned data, these results indicate that *lethal 1* coincides with [*CG17514*](https://identifiers.org/bioentitylink/FB:FBgn0039959?doi=10.1534/g3.119.0003){#ext-link-44955245eac2a2bda04acdaa5d80ca6d}.

###### RNAi experiments expressing *CG17514 RNAi*-activating *IRs* with *tub*-driven *GAL4* (at 29 C) suggest that *CG17514* is essential. However, viable progeny emerge when using the *eIF-4B RNAi* line (VDRC 31364). \*Escapers emerging from the VDRC 47269 *CG17514* RNAi cross display a *Minute* phenotype and are sterile

  Female parent                                    Balancer progeny   RNAi driven progeny   \% of expected RNAi flies
  ------------------------------------------------ ------------------ --------------------- ---------------------------
  ***CG17514 RNAi / CG17514 RNAi (VDRC 47269)***   195                17\*                  9% (semi-lethal)
  ***CG17514 RNAi / CG17514 RNAi (BL34355)***      303                0                     0% (lethal)
  ***CG17514 RNAi / CG17514 RNAi (VDRC 47268)***   151                105                   63% (viable)
  ***eIF-4B RNAi /eIF-4B RNAi (VDRC 31364)***      196                109                   71% (viable)
  ***eIF-4B RNAi /CyO (BL57305)***                 324                123                   \>100% (viable)

However, these results do not exclude an essential role for the *eIF-4B* gene as well, given its presumed key role in protein. It is quite possible that our screens did not isolate any mutations in this smaller target gene, although results from RNAi experiments do not suggest that eIF-4B is essential either (see below).

Molecular characterization of lethal 7A {#section-73bf1016491c8cd19aa90db5bbced761}
---------------------------------------

We currently possess only a single EMS induced allele of *lethal 7A*, *l(3)fsa^2^* ([@bib18]). This allele displays a lethal phase during late embryogenesis, with no obvious cuticle defects ([@bib18]). Molecular and genetic mapping show that *lethal 7A* is distal to *lethal 5* and proximal to *lethal 7B (scarecrow)* (see *e.g.*, [Figure 6A](#fig6){ref-type="fig"}). Two gene models, CG40002 and CG40472 (an apparent pseudogene of CG40002), appear the most likely candidates for *lethal 7A*. The *CG40002* gene encodes a 94 a.a. protein that is a member of the NADH dehydrogenase complex (a.k.a. Complex I). The NADH dehydrogenase complex is a conserved complex present throughout Eukarya and is the first major complex in the electron transport chain ([@bib50]). Given the important role of Complex I in the oxidative production of ATP, it would not be surprising if a gene encoding any of its subunits were essential.

![Mapping of *lethal 7A to CG40002*. A) Single embryo PCR mapping positions *CG40002* in the *lethal 7A* region. B) sePCR of DNA from *l(3)fsa^2^*mutants using *CG40002*, *med21* and *ucrh* primers. The asterisk marks a band that is amplified only from *l(3)fsa^2^*/*TM3* animals and likely corresponds to a polymorphic *ucrh* sequence found on this particular *TM3* balancer chromosome.](1581f6){#fig6}

There are also two other possible candidate gene models, *med21* and *ucrh*, in the vicinity. However, upon PCR mapping, we found that only the *CG40002* gene has been deleted in DNA from homozygous *l(3)fsa*^2^ mutant embryos, while *med21* and *ucrh* remain present ([Figure 6C](#fig6){ref-type="fig"}). This strongly suggests that *lethal 7A* corresponds to *CG40002*.

RNAi knockdown of heterochromatic genes {#section-3b86a38129a5161351bb07511d8114ba}
---------------------------------------

Some 3L Het genes that were predicted to have important functions based on the existence of conserved human homologs did not yield mutant alleles in our screens. In order to test for additional essential genes in 3L Het, we performed RNAi knockdown analysis using relevant RNAi lines available from the VDRC, TRiP or NIG collections, which allowed us to target most 3L Het gene models. Each RNAi line was crossed to *UAS-Dcr2/UAS-Dcr2*; tub-Gal4/TM3 [Sb](https://identifiers.org/bioentitylink/FB:FBgn0003319?doi=10.1534/g3.119.0003){#ext-link-f80ee1fcfcec6edcf0de37f199e6ea4b} at 29°; *UAS-Dcr2* was used to optimize the RNAi pathway and therefore increase the likelihood of detecting gene knockdown effects. The results identify 9-10 additional essential genes in 3L Het (10 if *nAchRalpha4* is included, see Discussion below) not previously identified in mutagenesis studies ([Tables 5](#t5){ref-type="table"} and [6](#t5){ref-type="table"}). As positive controls, we used some RNAi transgenes targeting known lethal complementation groups, and these were found to be effective.

###### Summary of RNAi experiments targeting genes in 3L Het. Column 1: The 3L Het genes targeted; Column 2: The identifier numbers of RNAi lines, appended with abbreviated prefixes indicating where they were sourced from (V - VDRC, BL - Bloomington Stock Center or NIG - National Institute of Genetics (Japan)); Column 3: Effects of driving RNAi on survival to adulthood and fertility (V - viable, L -lethal, SL - semi-lethal - *i.e.*, substantially less than 50% of expected progeny, F - fertile, S - sterile, IN - inconclusive, NT - not tested, M - male and FE -- female % - for semi-lethal lines, percentage of RNAi progeny emerging relative to that expected from balancer classes); Column 4: Phenotypes observed in multiple *RNAi*-driven flies, where applicable; and Column 5: Predicted function based on homologous protein structure or functional studies

  3L Het gene targeted (from proximal to distal)   RNAi lines used:                     Effects of driving RNAi lines:                      Phenotypes observed:                                                                  Encoded function targeted:
  ------------------------------------------------ ------------------------------------ --------------------------------------------------- ------------------------------------------------------------------------------------- ---------------------------------------------------------------
  *CG17514/lethal1*                                V47268, V47269, BL34355              V/F, SL (M: 9%, FE: 8%)/S, L                        Thin thoracic bristles, tergite defects, body elongation, held out/blistered wings.   Translational activator.
  *eIF-4B*                                         V31364, BL57305                      V/F, V/F                                            Thin or missing thoracic bristles (V31364).                                           Translational initiation factor (may have an accessory role).
  *dbp80*                                          BL3468, V109742                      SL (M: 17%, FE: 18%)/S, L                           Kinked bristles, tergite defects, wings held out or appear blistered.                 RNA helicase. May be required for nuclear export of RNA.
  *rpl15/lethal2*                                  not tested                           N/A                                                                                                                                       Component of the ribosome.
  *vtd/lethal3*                                    not tested                           N/A                                                                                                                                       Sister chromosome cohesion, gene expression.
  *CG40228*                                        V110000                              SL (M: 11%, FE: 12%)/F                              Ectopic thorax bristles, melanotic spots, flipped out wings.                          Transcriptional elongation factor. Component of ELL?
  *CG42598^%^*                                     V109076                              V/F                                                 Flies appear wider, segments elongated, flipped out wings.                            Unknown.
  *CG41284^%^*                                     V109076                              V/F                                                 Flies appear wider, segments elongated, flipped out wings.                            Unknown.
  *CG40160*                                        V109559, BL44268                     L, V/F                                                                                                                                    Peptidase.
  *CG40178/lethal4A*                               V110089, BL44578                     L, L                                                                                                                                      Thioredoxin, chaperone.
  *FASN3 (CG17374)/lethal4B*                       CG17374-2M, 3M                       L, L                                                                                                                                      Fatty acid synthase.
  *CG45782*                                        V109249, BL38367, V109094, BL40876   V/S (M only), V/F, L, L                                                                                                                   Sucrose transporter.
  *Ucrh/*UQCR-11                                   not tested                           N/A                                                                                                                                       Oxidative phosphorylation.
  *med21 (CG17397)*                                BL34731, V31940 V109982, V13667      L, V, L, L                                                                                                                                Transcriptional initiation, component of mediator.
  *dSet1/lethal5*                                  V40682, V40683, V10833, V45267       L, L, L, L                                                                                                                                H3K4 di- and tri-methylase.
  *CG40002^%^*/*ND-AGGG*                           V109239, BL43285                     V/F, V/F                                                                                                                                  Oxidative phosphorylation.
  *CG40472^%^*                                     nothing available                    N/A                                                                                                                                       Oxidative phosphorylation.
  *scro/lethal7B*                                  V33902                               L                                                                                                                                         Cell-specific transcription factor.
  *mRps5/lethal8*                                  BL36202                              L                                                                                                                                         Mitochondrial ribosomal protein.
  *nvd/lethal6*                                    not tested                           N/A                                                                                                                                       Ecdysone biosynthesis, molting/metamorphosis.
  *snap-25*                                        BL27306, BL34377                     V/F, L                                                                                                                                    SNARE protein, exocytosis.
  *CG40045*                                        V109167                              V/F                                                                                                                                       E2 ubiquitin conjugating enzyme.
  *CG40470*                                        not tested                           N/A                                                                                                                                       Peptidase.
  *CG43968*                                        nothing available                    N/A                                                                                                                                       Unknown, may be secreted.
  *CG17698*                                        V35634, V105884                      V/F, L                                              Curved/kinked thoracic bristles.                                                      Calmodulin dependent kinase, calcium signaling.
  *CG40298*                                        nothing available                    N/A                                                                                                                                       Unknown.
  *CG17454*                                        V20458, BL43199                      L, L                                                                                                                                      Spliceosome component.
  *ago3*                                           not tested                           N/A                                                                                                                                       piRNA biogenesis, germline silencing of transposons.
  *alpha-Cat*                                      V19182, V20123                       L, L                                                                                                                                      Cellular adhesion, adherens junction formation.
  *CG32230/ND-MLRQ*                                V9804, V10316, V101482               V/F, V/F, V/F                                       Melanin deposits on some flies.                                                       Oxidative phosphorylation.
  *nAChRa4*                                        V11392, BL31985, V12441              SL/F (M: 0%, FE: 9%), V/F, SL (M: 19%; FE: 29%)/F                                                                                         n-acetylcholine receptor, neurotransmission.
  *CG34031*                                        V109096                              V/F                                                                                                                                       Unknown.
  *vps11/CG32350*                                  V24731, V107420                      L, V/F                                                                                                                                    Vacuolar protein sorting, lysosomes/late endosome function.
  *CG33217*                                        V47818, V103309, BL43315, BL43167    L, L, L, L                                                                                                                                Unknown.
  *CKIIalpha*                                      not tested                           N/A                                                                                                                                       Diurnal rhythm regulation, involved in cell signaling.
  *rpL10/Qm*                                       V19083, V19084                       L, L                                                                                                                                      Component of the ribosome.
  *nrm*                                            V44176, BL52945                      V/F, V/F                                                                                                                                  Adhesion at neuromuscular junctions.
  *CG32457*                                        V15966, V15968                       L, SL (M: 0%, FE: 10%)/F                            Wings often not folded out in male escapers.                                          Unknown.
  *CG32461*                                        V26149, V26150, V108971              V/F. V/F, V/F                                                                                                                             Unknown.

^%^The sequences of these genes are very similar and are likely to result from annotation issues or more improbably, very recent duplications.

###### Essential genes in 3L Het identified to date

  Essential genes in 3L Het. (centromere outwards):   Determined essential based on:                         Sources:
  --------------------------------------------------- ------------------------------------------------------ ----------------------------------------------
  *CG17514/lethal1*                                   Lethality (muts/RNAi)/Male and fem. sterility (RNAi)   this study
  *dbp80*                                             Male and fem. sterility (RNAi)                         this study, Yan *et al.*, 2014
  *rpl15/lethal2*                                     Lethality (muts)                                       this study, [@bib59]
  *vtd/lethal3*                                       Lethality (muts/RNAi)                                  [@bib19], this study (muts), [@bib65] (RNAi)
  *CG40160*                                           Lethality (RNAi)                                       this study
  *CG40178/lethal4A*                                  Lethality (muts/RNAi)                                  this study
  *FASN3/lethal4B*                                    Lethality (muts/RNAi)                                  this study
  *CG45782*                                           Male sterility (RNAi)                                  this study
  *dSet1/lethal5*                                     Lethality (RNAi/muts)                                  [@bib20], this study
  *med21*                                             Lethality (RNAi)                                       this study
  *CG40002/lethal7A*                                  Lethality (muts)                                       this study
  *scro/lethal7B*                                     Lethality (RNAi/muts)                                  this study
  *mRps5/lethal8*                                     Lethality (muts/RNAi)                                  this study, Yan *et al.*, 2014
  *nvd/lethal6*                                       Lethality (muts/RNAi)                                  [@bib68] (RNAi), Syrzycka *et al.* in prep
  *snap-25*                                           Lethality (muts/RNAi)                                  [@bib66] (muts), this study (RNAi)
  *CG17698*                                           Lethality (RNAi)                                       this study
  *CG17454*                                           Lethality (RNAi)                                       this study
  *ago3*                                              Female sterility (muts)                                this study, [@bib38] (muts)
  *alpha-Cat*                                         Lethality (muts, RNAi)                                 [@bib56] (muts), this study (RNAi)
  *nAChRalpha4*[\*](#t6n1){ref-type="table-fn"}       Lethality (RNAi)                                       this study
  *CG32350*                                           Lethality (RNAi)                                       this study
  *CG33217*                                           Lethality (RNAi)                                       this study
  *CKIIalpha*                                         Lethality (muts)                                       [@bib39] (muts)
  *rpL10/Qm*                                          Lethality (muts, RNAi)                                 [@bib9] (muts), this study (RNAi)
  *nrm*                                               Lethality (muts)                                       [@bib32], [@bib31] (muts)
  *CG32457*                                           Lethality/Sterility (RNAi)                             this study

^%^The sequences of these genes are very similar and are likely to result from annotation issues or more improbably, very recent duplications.

Potential essential gene identified based on failure to recover males in a single RNAi line. Note that this result is not entirely conclusive, as this RNAi line also has 1 predicted off-target.

Summary of essential genes in 3L heterochromatin {#section-00a725cabb0bd3a7a2e14e2a5dd5064b}
------------------------------------------------

The essential 3L Het genes identified either through isolation/analysis of mutant alleles or RNAi analysis are shown in [Figure 7](#fig7){ref-type="fig"} and listed in [Table 6](#t6){ref-type="table"}. Overall, our data suggest that at least 25/39 genes (roughly 2/3) of genes in 3L Het are essential (26/39 if we include *nAchRalpha4* as a putative lethal), an unexpectedly large proportion relative to the roughly 1/3 of euchromatic genes that are predicted to be essential based on analyses of specific euchromatic regions (see Discussion). In addition, it is possible that our estimate of essential 3L genes is conservative and the number of essential genes in this region may be higher. We aren't able to readily estimate whether more genes may have been missed in our mutagenesis screens (see [@bib24] for a discussion of this point), and there is currently an absence of genetic reagents (RNAi constructs, other) for studying some 3L Het gene models.

![Map of essential genes present in 3L Het (not to scale). Blue- genes identified by us as essential through RNAi screening; red- genes identified by us as essential through mutants; black -- genes identified by others as essential. \*marks the uncertain status of *nAchRa4*, as discussed above.](1581f7){#fig7}

Unassigned lethal mutations generated in the current study {#section-21b5f66ec2d0c15c424c88cffc4984ee}
----------------------------------------------------------

A number of lethal mutations characterized in our study have not yet been assigned to known complementation groups but may be located in 3L Het. For example, the *Df(3L)XXX* allele from the initial X-ray screen fails to complement *Df(3L)γ-28*, but it does complement *Df(3L)1-166* and *Df(3L)FX33* (see [Figure 4](#fig4){ref-type="fig"}, *Df(3L)XXX* not shown on map), suggesting that an additional essential gene may reside between the lethal 7B /[scarecrow](https://identifiers.org/bioentitylink/FB:FBgn0028993?doi=10.1534/g3.119.0003){#ext-link-c805e490f387335f814711f0f6bdeba4} and *lethal 8* loci. There are also several EMS lesions that fail to complement *Df(3LR)6B-29*, but which have not been assigned to any known complementation group. While some of these may be alleles of second-site mutations on the *Df(3LR)6B-29* chromosome, outside of 3L Het, others may represent alleles of unidentified essential 3L Het loci *e.g.*, *Z-855* and *Z-5460* clearly map to 3L Het, but they complement alleles of all known essential 3L Het complementation groups. In addition, *Z-1326* and *Z-1605* were identified on the basis of failure to complement *Df(3L)Delta1-AK* and remain unassigned; however, while these alleles may correspond to distally located 3L Het genes, it is also possible that they are alleles of euchromatic genes at the heterochromatic/euchromatic border which have not yet been well characterized. Further work is necessary to determine the basis of all of the unassigned mutations; however, the next release of an updated *Drosophila* genome sequence should make it possible to identify and characterize more of these uncharacterized loci.

Discussion {#section-a1bc68f6dc04e06a1ed4b4e306b62a96}
==========

The work reported here links a detailed genetic map of 3L Het with the physical map available on Flybase. In the process, we have been able to assign molecular identities to most of our lethal complementation groups in 3L Het, which in the past have only been studied at a genetic level. Since full characterization of any genome is incomplete without an analysis of heterochromatin, our work provides an initial platform for the functional annotation of essential genes residing within these fascinating, yet poorly understood, regions of the genome. Our collection of mutant strains will be useful for studying the function of heterochromatic genes that have resisted characterization due to their location in a genetically less tractable region of the genome.

Using RNAi knockdown analyses, we have identified an additional group of essential 3L Het genes not identified in mutagenesis screens. Lethality associated with RNAi gene targeting provides good evidence that a gene is essential: the possibility of RNAi off-target effects seems unlikely because for all but one of the genes tested for RNAi knockdown effects, there were no detectable homologies to the 19 b.p. gene regions used in the RNAi transgene design (data not shown); moreover, off-targeting effects in flies have been reported as being very low ([@bib12]). The single exception involved two VDRC RNAi lines targeting the [*nAChRalpha4*](https://identifiers.org/bioentitylink/FB:FBgn0266347?doi=10.1534/g3.119.0003){#ext-link-a5c3733771c91123234b918434a9ba5a} gene; each of these exhibits a single predicted 19 b.p. off-target dsRNA; however, the majority of dsRNAs available for this gene do result in gene specific targeting, and therefore this single off-target RNA may be inconsequential. A homozygous viable allele of [*nAChRalpha4*](https://identifiers.org/bioentitylink/FB:FBgn0266347?doi=10.1534/g3.119.0003){#ext-link-31fecd82cc55ac425d9e4e1b6d54d859} has recently been reported to exhibit circadian defects ([@bib60]). However, since this allele is associated with a single amino acid substitution and was obtained in a screen for viable modifier mutations, it is likely not a null allele. If the effects on viability we observe by expressing [*nAChRalpha4*](https://identifiers.org/bioentitylink/FB:FBgn0266347?doi=10.1534/g3.119.0003){#ext-link-c40c26baed6d2cf7da2ffc974c65b23a} RNAi lines result from direct gene-targeting, the *nAchRalpha4* protein is likely essential and may have additional biological roles.

There remain some 3L Het gene models for which we have neither RNAi lines nor mutants, so at this point it is not possible to define whether any of these genes are essential. Furthermore, the observed viability when expressing available RNAi lines for certain genes does not prove that these genes are non-essential; an RNAi line may be poorly-expressed or substantial maternal effects may allow survival and thus obscure the effects of RNAi targeting. Indeed, gene expression studies showed that several RNAi lines tested only modestly reduced expression of the target genes (data not shown). Finally, while it seems likely that eIF-4B should also be essential, based on its presumed cell function, it is noteworthy that our results, as well as other RNAi analyses to date (<http://www.genomernai.org/v17/fullPagePhenotypes/gene/3355041>) are not consistent with an essential role for this protein (although again, similar caveats apply).

In terms of other potential caveats, lethal phenotypes resulting from RNAi knockdowns may not indicate that a gene is essential, because in some cases, genetic mutations knocking out the same gene do not show a lethal phenotype. This relatively rare phenomenon has been attributed to other factors such as genetic compensation ([@bib54], and refs therein).

Other strategies could be employed to determine whether any of the remaining 3L Het genes are essential. For example, since transposon insertions near genes of interest are becoming increasingly available, these could serve as starting points for generating imprecise excisions that affect adjacent genes. In addition, genetic screens for mutations lethal *in trans* to the distal-most 3L Het deficiencies (*Df(3L)TTT* or *Df(3L)1677)* may yield more lethal mutations between *ago3* and [*RpL10*](https://identifiers.org/bioentitylink/FB:FBgn0024733?doi=10.1534/g3.119.0003){#ext-link-62cf5f757740dc9364454cf9e96b5dc3}. Analysis of the latter 3L Het segment has proved difficult because deletions that remove the [*RpL10*](https://identifiers.org/bioentitylink/FB:FBgn0024733?doi=10.1534/g3.119.0003){#ext-link-9767ac90663cf9a7b1e9ebfaaf238a10} locus exhibit dominant semi-lethality and female sterility (K. Fitzpatrick unpublished observations). Lastly, with the innovations of CRISPR technology, plus the availability of newer targeted genetic reagents (*e.g.*, Mi{MIC} and Mi{Trojan-GAL4.0} alleles, see Flybase), it may be possible to extend the current work, although there could be issues with accessibility of DNA sequences when packaged in the chromatin environment of centric heterochromatin.

The findings from this and other studies indicate that although gene density is relatively low in centric heterochromatin, many genes located in this chromatin environment are functionally important. The essential genes identified in the current study appear to span a diverse set of molecular and developmental functions. We and others have noted that there is no correlation between developmental or other specific expression patterns and the location of genes within 3L and other centric Het regions. Although the size of an average heterochromatic gene is considerably larger than that of a typical euchromatic gene, neither is there any apparent correlation between heterochromatic gene size and whether a given gene is essential. While our mutagenesis experiments often produced mutations in larger 3L Het genes (based both on physical locus and gene product length), mutant alleles of some smaller essential genes (*rpl15* and *CG40002*) were also isolated, and several other small essential genes (such as *med21* and [*CG17454*](https://identifiers.org/bioentitylink/FB:FBgn0039977?doi=10.1534/g3.119.0003){#ext-link-91b4cf5de20c6ab32393666c13f8d54d}) were identified through RNAi experiments. Thus, although our results indicate an unexpectedly higher proportion of essential genes in 3L Het, there are no obvious properties that distinguish them from euchromatic genes.

As mentioned, our data suggest that approximately 2/3 of genes residing in 3L Het are required for developmental viability and/or adult fertility. In contrast, it is estimated that only about 1/3 of euchromatic genes are essential ([@bib47]; [@bib4]; [@bib12]; [@bib7]). It remains to be determined whether the large proportion of essential genes in 3L Het is significant or results from the relatively small sample size: in 3R Het, only four of the 11 genes appear to be essential (our unpublished observations), while the overall proportion of essential genes in 2R and 2L Het remains to be established.

The work described here, and the genetic tools generated, provide a foundation for advancing our understanding of the organization, functions and regulation to genes in these unique chromosomal regions. Fly stocks from this work, including representative Dfs across 3L and 3R Het, lethal alleles of individual genes, as well as other reagents (cDNA transgene and RNAi lines) will be available from the Bloomington *Drosophila* Stock Center, Indiana.
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